288 related articles for article (PubMed ID: 28110258)
1. IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Sun YC; Liu PY; Ko YL
Atherosclerosis; 2017 Feb; 257():71-77. PubMed ID: 28110258
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.
Bickel C; Schnabel RB; Zengin E; Lubos E; Rupprecht H; Lackner K; Proust C; Tregouet D; Blankenberg S; Westermann D; Sinning C
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):168-175. PubMed ID: 27773468
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases.
Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Ko YL
Biomark Med; 2019 Jun; 13(9):751-760. PubMed ID: 31157557
[No Abstract] [Full Text] [Related]
5. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
[TBL] [Abstract][Full Text] [Related]
6. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
7. Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease.
Daffara V; Verdoia M; Rolla R; Nardin M; Marino P; Bellomo G; Carriero A; De Luca G;
Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):775-783. PubMed ID: 28779988
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
[TBL] [Abstract][Full Text] [Related]
9. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Effects of Weighted Genetic Risk Scores and Resistin and sST2 Levels on the Prognostication of Long-Term Outcomes in Patients with Coronary Artery Disease.
Chou HH; Hsu LA; Juang JJ; Chiang FT; Teng MS; Wu S; Ko YL
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457109
[TBL] [Abstract][Full Text] [Related]
11. Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21.
Gioli-Pereira L; Santos PC; Ferreira NE; Hueb WA; Krieger JE; Pereira AC
BMC Cardiovasc Disord; 2012 Aug; 12():61. PubMed ID: 22856518
[TBL] [Abstract][Full Text] [Related]
12. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner.
Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A
Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions.
Hishikari K; Kimura S; Yamakami Y; Kojima K; Sagawa Y; Otani H; Sugiyama T; Kuwahara T; Hikita H; Takahashi A; Isobe M
Atherosclerosis; 2015 Apr; 239(2):583-8. PubMed ID: 25733330
[TBL] [Abstract][Full Text] [Related]
14. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
15. The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.
Osadnik T; Strzelczyk JK; Lekston A; Reguła R; Bujak K; Fronczek M; Gawlita M; Gonera M; Wasilewski J; Szyguła-Jurkiewicz B; Gierlotka M; Gąsior M
BMC Cardiovasc Disord; 2016 Nov; 16(1):218. PubMed ID: 27835972
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.
Pereg D; Elis A; Neuman Y; Mosseri M; Segev D; Granek-Catarivas M; Lishner M; Hermoni D
Coron Artery Dis; 2014 Jan; 25(1):79-82. PubMed ID: 24128887
[TBL] [Abstract][Full Text] [Related]
17. Influence of 677 C-->T polymorphism of methylenetetrahydrofolate reductase on medium-term prognosis after acute coronary syndromes.
García-Pinilla JM; Espinosa-Caliani S; Jiménez-Navarro M; Gómez-Doblas JJ; Cabrera-Bueno F; Reyes-Engel A; de Teresa-Galván E
Tex Heart Inst J; 2007; 34(2):142-7. PubMed ID: 17622358
[TBL] [Abstract][Full Text] [Related]
18. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
19. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
20. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.
Tragante V; Doevendans PA; Nathoe HM; van der Graaf Y; Spiering W; Algra A; de Borst GJ; de Bakker PI; Asselbergs FW;
Eur Heart J; 2013 Oct; 34(37):2896-904. PubMed ID: 23828831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
